Factor Influencing Breast Surgery Type Decision-Making

• Sponsor: Etienne El Helou (Other)
• Overall Status: Completed
• CT.gov ID: NCT05604677
• Collaborator: (none)
• Enrollment: 380
• Location: 1
• Actual Duration (Months): 2.1
• Patients Per Site Per Month: 177.9

Study Details

Study Description

Brief Summary

The aim of this observational study is to determine the factors influencing the decision-making process for breast surgery type, in Lebanese women likely to face breast cancer.

The main questions it aims to answer are the presence or not of a correlation between the type of choice and the following data:

• Demographic

• Health Status

• Several factors that may influence the decision

Participants will complete a well-structured and organized online survey

Condition or Disease	Intervention/Treatment	Phase
Breast Neoplasm	Procedure: Breast Surgery

Study Design

• Study Type: Observational [Patient Registry]
• Actual Enrollment: 380 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: Factors Influencing the Decision-making Process for Breast Surgery in Women Likely to Face Breast Cancer.
• Actual Study Start Date: Jun 15, 2022
• Actual Primary Completion Date: Jul 31, 2022
• Actual Study Completion Date: Aug 19, 2022

Outcome Measures

Primary Outcome Measures

1. Influencing Factors [2 months]

   Factors influencing breast surgery type decision making process

Eligibility Criteria

Criteria

• Ages Eligible for Study: N/A and Older
• Sexes Eligible for Study: Female

Inclusion Criteria:

• Lebanese Females

Exclusion Criteria:

• None

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	HelouEl	Baabda	Mount Lebanon	Lebanon	1003

Sponsors and Collaborators

• Etienne El Helou

Investigators

• Principal Investigator: Etienne El-Helou, MD, Dr Etienne El Helou

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Etienne El Helou, Principal Investigator, Dr Etienne El Helou
• ClinicalTrials.gov Identifier: NCT05604677
• Other Study ID Numbers: HelouEl
• First Posted: Nov 3, 2022
• Last Update Posted: Nov 7, 2022
• Last Verified: Nov 1, 2022

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Etienne El Helou, Principal Investigator, Dr Etienne El Helou: Breast Cancer; Mastectomy; Breast Conserving Surgery; Lebanese Population; Surgical Choice; Oncoplastic Surgery
• Additional relevant MeSH terms: Breast Neoplasms

Study Results

No Results Posted as of Nov 7, 2022